Dyno Therapeutics Launches to Improve Viral Vectors for Gene Therapy

Press

December 16, 2019

Press

Published

December 16, 2019

More like this

The 2020 National Xconomy Awards Winner - Startup of the Year

September 4, 2020

The 2020 National Xconomy Awards Winner - Startup of the Year

September 4, 2020

Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases

October 24, 2024

Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases

October 24, 2024

Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies

October 25, 2023

Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies

October 25, 2023

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy